1 / 22

GLP-1 Receptor Agonists: How Early Is Appropriate?

GLP-1 Receptor Agonists: How Early Is Appropriate?. Goals. Differentiation of GLP-1-RAs. Antihyperglycemic Therapy in Type 2 Diabetes: General Recommendations. Potential Clinical Advantages of GLP-1 Receptor Agonists. Physiologic Effects of GLP-1 Receptor Agonists.

jacob-cervantes
Download Presentation

GLP-1 Receptor Agonists: How Early Is Appropriate?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GLP-1 Receptor Agonists: How Early Is Appropriate?

  2. Goals

  3. Differentiation of GLP-1-RAs

  4. Antihyperglycemic Therapy in Type 2 Diabetes: General Recommendations

  5. Potential Clinical Advantagesof GLP-1 Receptor Agonists

  6. Physiologic Effects of GLP-1 Receptor Agonists

  7. Potential for GLP-1 RAs as First-Line Therapy

  8. Choosing Between Agents With Low Rates of Hypoglycemia

  9. Potential Clinical Disadvantagesof GLP-1 Receptor Agonists

  10. Potential of Once-Weekly GLP-1 Receptor Agonists: Exenatide QW

  11. Combining Basal Insulin With a GLP-1 Receptor Agonist

  12. Fixed Formulation

  13. Once-Weekly GLP-1 RA in Combination With Basal Insulin*

  14. Novel Emerging Strategies

  15. Safety – Patient Education

  16. Closing Comments

  17. Abbreviations

  18. References

  19. References (cont)

  20. References (cont)

  21. References (cont)

More Related